Natalya S. Solovieva

Natalya S. Solovieva

Auto-generated profile, based on publicly available information

Natalya S. Solovieva

St. Petersburg Research Institute of Phthisiopulmonology, St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Tuberculosis
Verified
Journal Article
Closed access
AVAnna Vyazovaya
Anna Vyazovaya
EPEugeniya Proshina
Eugeniya Proshina
AGAlena Gerasimova
Alena Gerasimova
IAIon Avadenii
Ion Avadenii
NSNatalia Solovieva
Natalia Solovieva
IMIgor Mokrousov
Igor Mokrousov

18 December 2023 in Russian Journal of Spine Surgery (Khirurgiya Pozvonochnika)
Verified
Journal Article
Open access
PDF file
DNDenis Naumov
Denis Naumov
AVArkadiy Аnatolievich Vishnevskiy
Arkadiy Аnatolievich Vishnevskiy
NSN. S. Solovieva
N. S. Solovieva
НМНаталья Юрьевна Масалова
Наталья Юрьевна Масалова
PYP. K. Yablonsky
P. K. Yablonsky
ПЯПетр Казимирович Яблонский
Петр Казимирович Яблонский
Objective. To analyze the results of the continuous monocentric 5-year microbiological monitoring of causative agents of surgical site infection (SSI) in patients who underwent primary surgery for chronic infectious spondylitis and required revision surgery.Material and Methods. The study included patient data from 2018 to 2022. The primary cohort included 569 consecutively operated patients with chronic infectious spondylitis of nonspecific (n1 = 214) and tuberculous (n2 = 355) etiology. The analyzed sample was formed taking into according to inclusion and exclusion criteria. Thus, in 99 patients who required revision surgical interventions due to the development of SSI, a continuous microbiological monitoring of pathogens was performed, including the assessment of drug resistance and the timing of the development of infectious complications. Periodization of the time of SSI development was performed according to the accepted classification of Prinz et al. (2020), the assessment of drug resistance spectrum was performed according to the EUCAST recommendations (2020) and taking into account the approved methodological recommendations.Results. In the general structure of surgical interventions for chronic infectious spondylitis, the share of revision interventions due to the development of SSI was 17.4 %. The highest incidence of complications was noted in the late postoperative period (χ2 = 9.237; p = 0.009). Bacterial detection from the material of vertebral localization was noted in 43 cases (48.3 %), pathogen strains were isolated in urine in 28 (60.8 %), in decubital ulcers in 11 (23.9 %) and in hemoculture in 7 (15.2 %) patients. Culture negative SSI was detected in 10 cases (10.1 %) in the late period. Infectious complications in the setting of chronic non-specific spondylitis were detected more frequently than in spondylitis of tuberculous etiology (χ2 = 21.345; p < 0.001). Gram-positive multidrug-resistant and Gram-negative bacteria with extreme resistance prevailed in the microbiological landscape of late SSI, and Gram-positive strains without drug resistance in that of early and delayed SSI (χ2 = 17.516; p = 0.0032).Conclusion. Drug-resistant Gram-positive bacteria predominate in the structure of SSI with a significantly higher frequency of complication development. Nonspecific etiology of spondylitis is associated with a significantly higher incidence of SSI. In the absence of a positive result of bacteriological examination of the material of vertebral localization, it is advisable to collect blood, decubital ulcer secretion and urine sampling.

22 November 2023 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
AVAnna Vyazovaya
Anna Vyazovaya
PEPlaton I. Eliseev
Platon I. Eliseev
AGAlena А. Gerasimova
Alena А. Gerasimova
NSNatalya S. Solovieva
Natalya S. Solovieva
ENElena I. Nikishova
Elena I. Nikishova
МОМарьяндышев Андрей Олегович
Марьяндышев Андрей Олегович
Introduction. Against the background of improvement of the main epidemiological indicators (morbidity and mortality) for tuberculosis in the Arkhangelsk region, the proportion of newly diagnosed tuberculosis patients with multidrug-resistant pathogen (MDR-TB) increased from 18.7% in 2002 to 33.8% in 2018. The purpose of this study was the genotypic characterization of Mycobacterium tuberculosis strains obtained from newly diagnosed tuberculosis patients in the Arkhangelsk region in 2018. Materials and methods. 89 M. tuberculosis strains isolated in 2018 from newly diagnosed tuberculosis patients were studied. Beijing genotype, its clusters B0/W148 and Central Asian/Russian were determined by PCR detection of the specific markers: IS6110 insertions in the dnaA-dnaN region, mutations in codons 48 of the mutT4 gene (CGG GGG) and 58 of the mutT2 gene (GGA CGA), IS6110 insertions in the Rv2664 region-Rv2665 and Rv1359-Rv1360, substitutions G A in the sigE gene. Non-Beijing strains were spoligotyped. Results. Drug resistance was detected in 41.6% (37/89), MDR — in 33.7% of strains. In 90% (27/30) of MDR strains, resistance to rifampicin and isoniazid was due to rpoB Ser531Leu and katG Ser315Thr mutations. Following M. tuberculosis genotypes were identified: Beijing (67.4%), T (14.6%), Ural (4.5%), Haarlem (4.5%), LAM (2.3%) and CAS1-Delhi (1.1%). Among the Beijing strains, clusters Central-Asian/Russian (60%; 36/60) and B0/W148 (30%; 18/60) prevailed. The majority of MDR strains belonged to the Beijing family (93.3%; 28/30), of which 64.3% (18/28) and 21.4% (6/28) belonged to clusters B0/W148 and Central-Asian/Russian, respectively. Conclusion. In heterogeneous population of the causative agent of tuberculosis in the Arkhangelsk region, the most common strains were those of the Beijing genotype; in 2018 its share increased to 67.4% (40.4% in 1998–1999). Among MDR strains, the proportion of Beijing reached 93.3%, of which more than half (64.3%) belonged to the epidemiologically and clinically significant in Russia cluster B0/W148.

16 July 2024 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
AVAnna Vyazovaya
Anna Vyazovaya
NSNatalia S. Solovieva
Natalia S. Solovieva
AGAlena A. Gerasimova
Alena A. Gerasimova
VZViacheslav Zhuravlev
Viacheslav Zhuravlev
IMIgor Mokrousov
Igor Mokrousov
СССоловьева Наталья Сергеевна
Соловьева Наталья Сергеевна
Introduction. Fluoroquinolones remain the key second-line anti-tuberculosis drugs. The aim of the study was the molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis strains from newly diagnosed tuberculosis patients in the Northwest of the Russian Federation. Materials and methods. The retrospective study collection included M. tuberculosis isolates isolated in 2015–2019 from previously untreated tuberculosis patients. Susceptibility to antituberculosis drugs (including the fluoroquinolone ofloxacin) was determined using the BACTEC MGIT960 or absolute concentration method. Mutations in the gyrA gene as a marker of resistance to fluoroquinolones, were detected by real-time PCR. Beijing genotype and its subtypes were detected by PCR and real-time PCR methods. Non-Beijing strains were spoligotyped. Results and discussion. Phenotypic resistance to ofloxacin was detected in 6.7% (40/599) of strains and in 17.4% (40/230) of MDR strains. 34 of 40 (85%) ofloxacin-resistant strains belonged to the Beijing genotype. 18 (45%) strains were assigned to the Russian epidemic subtype Beijing B0/W148 and 12 (30%) to Beijing Central Asian/Russian. The remaining 6 ofloxacin-resistant strains belonged to the Euro-American phylogenetic lineage. Mutations in the gyrA gene were found in 97.5% (39/40) of strains. The most common were mutations in codon 94 (69.2%, 27/39). The Asp94Gly substitution was identified in 57.5% (23/40) of ofloxacin-resistant strains and was dominant among Beijing (19/34) and non-Beijing (4/6) strains. The second most common substitution was Ala90Val (25%, 10/40). More than half of the ofloxacin-resistant strains, Beijing B0/W148 (10/18) and Central Asian/Russian (7/12), carried the Asp94Gly mutation. Conclusion. In the Northwest of Russia in 2016-2019, primary resistance of M. tuberculosis to fluoroquinolones was 6.7% in the total collection and 17.4% of MDR strains, and was mainly caused by the gyrA Asp94Gly and Ala90Val mutations. Beijing B0/W148 genotype was characterized by the largest proportion of fluoroquinolone-resistant strains.

30 December 2018 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
AVAnna Vyazovaya
Anna Vyazovaya
NSN. Solovieva
N. Solovieva
AGA. Gerasimova
A. Gerasimova
GAG. Akhmedova
G. Akhmedova
ETE. Turkin
E. Turkin
IMIgor Mokrousov
Igor Mokrousov
POPULATION STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS IN RUSSIAN REGIONS BORDERING EU COUNTRIES

1 June 2022 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
AVAnna Vyazovaya
Anna Vyazovaya
NGN. Yu. Gavrilova
N. Yu. Gavrilova
AGA. A. Gerasimova
A. A. Gerasimova
ABA. O. Bychkova
A. O. Bychkova
IAI. Avadenii
I. Avadenii
ONO. V. Narvskaya
O. V. Narvskaya
In Murmansk oblast, the first molecular-genetic studies of circulating strains of Mycobacterium tuberculosis were carried out during the years of an increa